|
University of Texas Medical Branch School of Medicine | |
| City: Galveston | State: TX | |
|
Links:
Updates: This institution's COI policies were evaluated on Jun-11-2014. This institution has indicated their policies have not changed since they were evaluated for 2014 Scorecard. |
||
| Gifts |  |
Industry-funded gifts are prohibited on-site but small gifts like pens are allowed if offered to all attendees at an off-site conference. [Domain Location: Policy 2, pgs. 5-6] |
| Meals |  |
No industry-funded meals of any nature or value allowed except in the case of 'appropriately sanctioned scientific or educational meetings.' [Domain Location: Policy 1, p 8; Policy 2, p 5] |
| Industry-funded promotional speaking relationships (not ACCME-accredited) | |
All members of the faculty are prohibited from participating in speaker bureaus or similar speaking arrangements AND the policy effectively ensures that the talk is not promotional in nature and that industry has no role in determining or approving presen [Domain Location: Policy 1, pgs. 3, 8-9; Policy 2, p 12] |
| Industry-support of ACCME-accredited CME |  |
Industry support can be accepted as long as ACCME standards are followed. The policy mentions that funds 'are provided to the school, department, division or program and not to the individual clinician.' However, this is not as strong as central managemen [Domain Location: Policy 2, pgs. 9-10] |
| Attendance of industry-sponsored promotional events | |
Attendance allowed (without any statement discouraging attendance) but attendees cannot accept industry reimbursement for travel or other remuneration. [Domain Location: Policy 1, p 8; Policy 2, p 12] |
| Industry-supported scholarships and awards | |
Industry may provide scholarships for meeting attendance, but it may not participate in the selection of attendees. [Domain Location: Policy 2, p 8] |
| Ghostwriting and honorary authorships | |
Ghostwriting is prohibited. [Domain Location: Policy 2, p 5] |
| Consulting and advising relationships | |
Consulting and advising relationships are allowed with safeguards in place, including prior approval and payment at fair market value. [Domain Location: Policy 1, pgs. 4-5; Policy 2, p 5; Policy 4] |
| Access of pharmaceutical sales representatives | |
Pharmaceutical representatives are allowed to meet with faculty but the meetings must take place only in non-patient care areas and the meetings must take place by appointment only. [Domain Location: Policy 2, p 7] |
| Access of medical device representatives | |
Access by device manufacturer representatives to patient care areas is permitted by appointment. Interactions with faculty must be related to 'evaluating or testing new technologies or services, setting up new equipment or devices already purchased or app [Domain Location: Policy 2, p 7] |
| Conflict of interest disclosure | |
Internal disclosure is required annually. [Domain Location: Policy 1, pgs. 6-7; Policy 4, pgs. 7-8] |
| COI curriculum | |
No policy provided. [Domain Location: No policy provided. ] |
| Extension of COI policies to community affiliates | |
All faculty, employees, and trainees are subject to the institution's COI policies, but the policy documents do not specify that the COI policies also cover them in all instances, locations, or whereabouts. [Domain Location: Policy 2, p 3; Policy 3, p 1] |
| Enforcement and Sanctions of Policies | |
There is a party responsible for oversight of the policy and there are sanctions for noncompliance included in the policy. [Domain Location: Policy 2, p 3; Policy 3, p 9; Policy 5, pgs. 6-7; Policy 6, pgs. 12-13] |
 | |
| Model policy |
| Good progress toward model policy |
| No policy, or policy unlikely to have a substantial effect on behavior |
